What's new

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 10, Status: Authorised

May 8, 2025 - 18:46
 0
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

FDA misses another approval decision target date, this time for GSK's Nucala in ...

Next Article

Fan Sues NFL For Emotional Distress Over Shedeur Sanders Draft

Related Posts

CTIS newsflash - 29 April 2025

Apr 29, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0

Questions and answers for biological medicinal products

Questions and answers for biological medicinal products

May 8, 2025  0